Screener
Celldex Therapeutics CLDX Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Grant | $15K-97.9% | $15K-97.7% | $48K-95.9% | $0-100% | $723K-71.1% | |
| Service | $7K0.0% | —— | $40K+400% | $0-100% | $7K— |
FAQ
- How does Celldex Therapeutics break its business down?
- Celldex Therapeutics (CLDX) reports revenue by product across 2 parts — Grant and Service. Each is extracted from the segment footnotes and tracked over time.
- Where does Celldex Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Celldex Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
